Trial · NCT05369039
Roflumilust in Chronic Rhinosinusitis With Nasal Polyposis.
NCT05369039, Phase 2, Unknown, Menoufia University
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Roflumilust in Chronic Rhinosinusitis With Nasal Polyposis. Trials, record NCT05369039. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT05369039
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Roflumilust in Chronic Rhinosinusitis With Nasal Polyposis.
- NCT number
- NCT05369039
- Status
- Unknown
- Phases
- Phase 2
- Enrollment
- 60 participants, estimated
- Lead sponsor
- Menoufia University
- Conditions
- Chronic Sinusitis
- Interventions
- Roflumilust, Prednisolone
- First posted
- 2022-05-11
- Last updated
- 2022-05-11
Source ClinicalTrials.gov
Registered outcomes7
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Comparison between pretreatment and posttreatment SNOT-22 score in both groups | 2 weeks after start of treatment | Post-treatment SNOT-22 scores will be compared with pretreatment scores in both groups |
| Primary | Comparison between pretreatment and posttreatment Lund Kennedy scores in both groups | Two weeks after start of treatment | Post-treatment Lund Kennedy scores will be compared with pretreatment scores in both groups |
| Primary | Comparison between pretreatment and posttreatment Serum periostin levels in both groups | Two weeks after start of treatment | Post-treatment Serum periostin level in pg/ml will be compared with pretreatment levels in both group |
| Primary | Comparison between case and control groups regarding SNOT 22 score | Two weeks after start of treatment | Case and control groups are compared regarding post-treatment SNOT-22 score |
| Primary | Comparison between case and control groups regarding Lund Kennedy score | Two weeks after start of treatment | Case and control groups are compared regarding post-treatment Lund Kennedy score |
| Primary | Comparison between case and control groups regarding serum periostin level | Two weeks after start of treatment | Case and control groups are compared regarding post-treatment serum periostin level in pg/ml |
| Secondary | Assessment of the side effects of Roflumilust | Two weeks after start of treatment | The side effects of Roflumilust will be assessed among the case group |
Source ClinicalTrials.gov
Outcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers5
The papers the trial lists on ClinicalTrials.gov.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT05369039
GET https://conductscience.org/api/trials/v1/NCT05369039/registered